Actively Recruiting
Assessment of Treatment Adherence and Associated Factors in Chronic Hepatitis B Patients With Supported Management by the HBVCare Application
Led by Institute of Gastroenterology and Hepatology, Vietnam · Updated on 2026-05-15
70
Participants Needed
2
Research Sites
4 weeks
Total Duration
On this page
Sponsors
I
Institute of Gastroenterology and Hepatology, Vietnam
Lead Sponsor
H
Hanoi Medical University Hospital, Vietnam
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating how the HBVCare mobile application can support adults living with chronic Hepatitis B in improving their adherence to treatment and regular follow-up visits. This is important because low adherence in Vietnam is linked to patient awareness and geographic challenges, which can lead to serious complications. The study is a randomized controlled trial conducted at multiple centers in Vietnam to assess the app's impact on treatment adherence and related health outcomes. Participants are randomly assigned to one of two groups: one group uses the HBVCare app, which offers medication reminders, lab result storage, and educational content; the other group receives standard care without the app. The intervention lasts for three months, during which participants in the app group receive instructions on using HBVCare to help manage their disease proactively. During the study, participants will have their treatment adherence assessed after three months. Researchers will also monitor changes in clinical symptoms, user experience with the app, patient satisfaction, and various laboratory measures related to liver health and viral load. The primary outcome is the proportion of patients demonstrating good treatment adherence at three months, with additional data collected to evaluate the app's usability and impact on health markers.
CONDITIONS
Brief Title
Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of Chronic Hepatitis B for 6 months or more (HBsAg positive and/or HBV DNA positive; or HBsAg positive and anti-HBc IgM negative)
- Own a smartphone (iOS or Android) with active internet and ability to install the HBVCare app
- Able to read and understand Vietnamese and respond to study questions
- Provided informed consent to participate
You will not qualify if you...
- Mental health disorders, cognitive impairment, or difficulties using mobile applications
- Severe chronic health conditions such as heart failure, kidney failure, or respiratory failure
- Severe complications including gastrointestinal bleeding, liver cancer, hepatic encephalopathy, or acute liver failure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months
Participants use the HBVCare mobile application or do not use it, based on random assignment, to support management of chronic Hepatitis B.
Baseline visit and 1 follow-up visit at 3 months
Trial Site Locations
Total: 2 locations
1
Hanoi Medical University Hospital
Hanoi, Vietnam, 100000
Actively Recruiting
2
Institute of Gastroenterology and Hepatology
Hanoi, Vietnam, 100000
Actively Recruiting
Research Team
T
Trung Quoc Vu
H
Hang Viet Dao, MD, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here